{"id":263,"date":"2016-11-30T11:01:21","date_gmt":"2016-11-30T11:01:21","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=263"},"modified":"2016-12-21T14:24:59","modified_gmt":"2016-12-21T14:24:59","slug":"xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","title":{"rendered":"Xarelto drug reportedly causing internal bleeding and one death a week"},"content":{"rendered":"

A stern warning for all patients prescribed the blood-thinning drug Rivaroxaban; sold under the name of Xarelto, that’s available on the NHS:<\/p>\n

Reports suggest that it’s causing one death a week from internal bleeding, which is extremely alarming. The German manufacturer of the product, Bayer, are currently facing legal actions from around the world.<\/strong><\/div>\n


\nXarelto is a type of blood-thinning medication prescribed as an alternative to medication like warfarin, and has been marketed as an effective medication to reduce life-threatening blood clots.<\/p>\n

However, investigations have found potentially lethal side-effects like internal bleeding, including bleeds on the brain; all of which are very serious and life-threatening.<\/p>\n

Concerns of its safety<\/h2>\n

Earlier this year, family doctor Des Spence voiced concerns and warned users about the risks of using the medication, saying: <\/p>\n

“This new and heavily promoted drug is being rapidly and widely used when there are still unforeseen and serious side effects. GPs should be warned about it.”<\/p><\/blockquote>\n

And this warning carries a serious amount of weight.<\/p>\n

As many as 1.5 million prescriptions of the medication were given to NHS patients last year; which is a lot of people to be at risk of serious internal bleeding.<\/p>\n

New figures from the U.K. Medicines and Healthcare products Regulatory Agency<\/strong> (MHRA) indicated there had been 76 deaths<\/strong> thought to be directly linked to the medication here in the U.K.<\/p>\n

Bayer’s reassurance<\/h3>\n

A spokesman for Bayer said that all treatments that require Xarelto will include an element of risk, but he went on to say that: “patient safety is always the highest priority”, and confirmed that they’ve undertaken study after study in more than 91,000 patients to keep a positive benefit-risk profile.<\/p>\n

But with patients at risk of internal bleeding and death, the benefits don’t appear to be outweighing the risks…<\/p>\n

U.S. class-action lawsuit<\/h3>\n

More than 14,000 plaintiffs, which include users and their relatives, have launched a class-action legal suit against Bayer in the U.S.<\/p>\n

As is common in large medical product cases like this, Bayer is not accepting any liability.<\/p>\n

It’s notably Bayer’s best-selling medicine, which generates around \u00a318 billion in revenue a year for the manufacturers. If Bayer admits to the direct link between the drug and the deaths, I would imagine there would be a steep drop in sales, and a costly litigation against them. On top of that, admitting that their drug is a cause of death would bring the pharmaceutical manufacturing company into mass disrepute.<\/p>\n

Mr McWilliams, a U.S. lawyer currently representing over 1,000 plaintiffs in their claims, has highlighted the fact that Bayer could have taken extra precautions. He notes that clinical measures aren’t enough, and says that the drug should be rigorously tested alongside the patient’s blood values. Again, the pharmaceutical company rejects these claims and insists that the drugs had been tested in compliance with all the necessary consumer safety standards.<\/p>\n

Bayer’s reported lack of pre-emptive measures<\/h3>\n

However, four years on from Xarelto’s approval, there has yet to be any remedy from the pharmaceutical company.<\/p>\n

Bayer has yet to offer any anti-haemorrhaging medication to counter the effects of the supposed deadly drug. Mr McWilliams expresses his disappointment through an analogy, saying: “it’s like putting a car on the market without any brakes”.<\/p>\n

This is certainly a very valid point.<\/p>\n

Has the manufacturer just let the drug loose on the market without thorough testing?<\/p>\n

There are known risk with all blood-thinning drugs, but the risks associated with Xarelto appear to me much more dangerous, and do not appear to have an antidote or reversal agent.<\/p>\n

There’s likely to be more and more claims against the pharmaceutical company off the back of the U.S. lawsuit – if it’s found that the company has released a dangerous drug which has misled the consumer about its safety, claims will rightly be made.<\/p>\n

UK Compensation<\/h3>\n

Our team of specialist Medical Negligence, Product, and Group Action Lawyers are investigating the issues for UK patients. We’ve recovered millions of pounds in compensation for claims over the years we have been fighting for the rights of victims, which includes helping people in big cases like PIP Breast Implant scandal<\/a> and the Metal-On-Metal Hip Implant claims<\/a><\/strong>.<\/p>\n

For more information:<\/p>\n

https:\/\/www.drugwatch.com\/xarelto\/internal-bleeding\/<\/a><\/p>\n

http:\/\/www.express.co.uk\/life-style\/health\/685621\/Heart-drug-blood-thinning-clots-Rivaroxaban-linked-severe-side-effects-deaths-NHS<\/a><\/p>\n

https:\/\/global.handelsblatt.com\/companies-markets\/bayer-faces-class-action-suit-over-stroke-drug-640291<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A stern warning for all patients prescribed the blood-thinning drug Rivaroxaban; sold under the name of Xarelto, that’s available on the NHS: Reports suggest that it’s causing one death a week from internal bleeding, which is extremely alarming. The German manufacturer of the product, Bayer, are currently facing legal actions from around the world.<\/p>\n","protected":false},"author":1,"featured_media":266,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5],"tags":[4],"class_list":["post-263","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","tag-compensation-claims"],"yoast_head":"\nXarelto Drug Reportedly Causing Internal Bleeding & One Death A Week<\/title>\n<meta name=\"description\" content=\"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xarelto Drug Concerns: Reportedly causing Internal Bleeding and ONE Death a Week\" \/>\n<meta property=\"og:description\" content=\"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-30T11:01:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-12-21T14:24:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i1.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns-large.png?fit=1200%2C801&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"801\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Xarelto drug reportedly causing internal bleeding and one death a week\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns-large.png?fit=1200%2C801&ssl=1\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Xarelto drug reportedly causing internal bleeding and one death a week\",\"datePublished\":\"2016-11-30T11:01:21+00:00\",\"dateModified\":\"2016-12-21T14:24:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\"},\"wordCount\":739,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/xarelto-concerns.png?fit=725%2C250&ssl=1\",\"keywords\":[\"compensation claims\"],\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\",\"name\":\"Xarelto Drug Reportedly Causing Internal Bleeding & One Death A Week\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/xarelto-concerns.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2016-11-30T11:01:21+00:00\",\"dateModified\":\"2016-12-21T14:24:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/xarelto-concerns.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/xarelto-concerns.png?fit=725%2C250&ssl=1\",\"width\":725,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xarelto drug reportedly causing internal bleeding and one death a week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xarelto Drug Reportedly Causing Internal Bleeding & One Death A Week","description":"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","og_locale":"en_GB","og_type":"article","og_title":"Xarelto Drug Concerns: Reportedly causing Internal Bleeding and ONE Death a Week","og_description":"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","og_site_name":"Group Action Lawyers","article_published_time":"2016-11-30T11:01:21+00:00","article_modified_time":"2016-12-21T14:24:59+00:00","og_image":[{"width":1200,"height":801,"url":"https:\/\/i1.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns-large.png?fit=1200%2C801&ssl=1","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_title":"Xarelto drug reportedly causing internal bleeding and one death a week","twitter_image":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns-large.png?fit=1200%2C801&ssl=1","twitter_misc":{"Written by":"Author","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Xarelto drug reportedly causing internal bleeding and one death a week","datePublished":"2016-11-30T11:01:21+00:00","dateModified":"2016-12-21T14:24:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week"},"wordCount":739,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1","keywords":["compensation claims"],"articleSection":["Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week","name":"Xarelto Drug Reportedly Causing Internal Bleeding & One Death A Week","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1","datePublished":"2016-11-30T11:01:21+00:00","dateModified":"2016-12-21T14:24:59+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"Reports allege Xarelto is causing one death a week from internal bleeding. Bayer, the manufacturer of the product, currently face worldwide legal actions.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1","width":725,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-drug-reportedly-causing-internal-bleeding-one-death-a-week#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Xarelto drug reportedly causing internal bleeding and one death a week"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1","jetpack-related-posts":[{"id":1561,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-side-effects-mixed-other-drugs","url_meta":{"origin":263,"position":0},"title":"Xarelto side-effects when mixed with other drugs","author":"Author","date":"27th April 2018","format":false,"excerpt":"The issue of Xarelto side-effects when mixed with other drugs is currently being considered as part of the ongoing court action for negligence claims against the manufacturers of Xarelto who allegedly failed to warn users of dangerous side-effects related to use of the drug. The blood-thinning, anti-stroke drug Xarelto -\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"anti-depressants prescriptions for children","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":1761,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/xarelto-compensation-settlements","url_meta":{"origin":263,"position":1},"title":"Xarelto compensation settlements","author":"Author","date":"16th April 2019","format":false,"excerpt":"Big news! Xarelto compensation settlements are taking place, with almost \u00a3600m in damages set to be paid out by Bayer AG and Johnson & Johnson. The settlements are for around 25,000 lawsuits in the U.S., where Bayer and J&J have reportedly agreed to settle the litigation for $775m. The Group\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1289,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/rivaroxaban-recall-reduced-strength-tablet-blister-strips","url_meta":{"origin":263,"position":2},"title":"Rivaroxaban recalled over rogue blister strips of reduced strength tablets","author":"Admin","date":"19th January 2018","format":false,"excerpt":"The Medicines and Healthcare Products Regulatory Authority (MHRA) has announced a recall over Xarelto 20mg film-coated tablets made by Strathclyde Pharmaceuticals Ltd. Better known as Rivaroxaban, the tablets are packaged into blister strips with the weight labelled on one side. A batch is reportedly affected by the recall following reports\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":838,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","url_meta":{"origin":263,"position":3},"title":"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination","author":"Admin","date":"24th July 2017","format":false,"excerpt":"A medical drug manufacturer has initiated a voluntary recall on 3rd July 2017 after concerns their Nifedipine tablets have become contaminated with other medication ingredients. The company, based in Iceland, makes the hypertension drug under the brand name Adalat, which is supplied to Bayer HeathCare. It's used for channel blocking\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":906,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","url_meta":{"origin":263,"position":4},"title":"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests","author":"Admin","date":"25th August 2017","format":false,"excerpt":"The drug Duloxetine, more commonly known as its brand name Cymbalta, is generally used to treat depression, anxiety, and chronic pain. It's an active 'serotonin-norepinephrine reuptake inhibitor', providing pain relief for patients with diabetes or sufferers from chronic or widespread pain. The drug is commonly prescribed to people with arthritis\u2026","rel":"","context":"In "Latest"","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3238,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/securing-mass-compensation-for-dangerous-drug-victims-through-group-actions","url_meta":{"origin":263,"position":5},"title":"Securing Mass Compensation for Dangerous Drug Victims Through Group Actions","author":"Author","date":"13th January 2026","format":false,"excerpt":"Pharmaceutical negligence can devastate lives, but victims no longer need to fight alone. The Group Action Lawyers specialises in uniting affected individuals to pursue mass compensation for dangerous drug cases via powerful group actions. This article explains how these claims work, who qualifies, and why joining forces can maximise your\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"mass compensation for dangerous drug","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-Group-action-6-Copy-min.jpg?fit=850%2C649&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-Group-action-6-Copy-min.jpg?fit=850%2C649&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-Group-action-6-Copy-min.jpg?fit=850%2C649&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-Group-action-6-Copy-min.jpg?fit=850%2C649&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=263"}],"version-history":[{"count":6,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/263\/revisions"}],"predecessor-version":[{"id":352,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/263\/revisions\/352"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/266"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}